• Goode RL. Diagnosis and Treatment of Turbinate Dysfunction: A Self-Instructional Package. American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc.; 1977.; • Harrill WC, Pillsbury HC 3rd, McGuirt WF, Stewart MG. Radiofrequency turbinate reduction: a NOSE evaluation. Laryngoscope. 2007 Nov;117(11):1912-9.; • Cavaliere M, Mottola G, Iemma M. Comparison of the effectiveness and safety of radiofrequency turbinoplasty and traditional surgical technique in treatment of inferior turbinate hypertrophy. Otolaryngol Head Neck Surg. 2005 Dec;133(6):972-8. • Coste A, Yona L, Blumen M, et al. Radiofrequency is a safe and effective treatment of turbinate hypertrophy. Laryngoscope. May 2001;111(5):894-9. ; • Hytönen ML, Bäck LJ, Malmivaara AV, Roine RP. Radiofrequency thermal ablation for patients with nasal symptoms: a systematic review of effectiveness and complications. Eur Arch Otorhinolaryngol. Aug 2009;266(8):1257-66.; • Bezerra TF, Padua FG, Pilan RR, Stewart MG, Voegels RL. Cross-cultural adaptation and validation of a quality of life questionnaire: the Nasal Obstruction Symptom Evaluation questionnaire. Rhinology. 2011 Jun;49(2):227-31 0 10 20 30 40 50 60 70 80 90 100 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 Before RFTR After RFTR n=32 Patient’s impact in quality of life (%) Quality of Life after Radiofrequency Turbinate Reduction Mafalda T. Soares MD, Inês Delgado MD, Teresa Gabriel MD, Ana Guimarães MD, Pedro Henriques MD, Filipe Freire MD Prof. Doutor Fernando Fonseca Hospital Amadora, Portugal INTRODUCTION RESULTS/DISCUSSION ABSTRACT METHODS AND MATERIALS CONCLUSIONS REFERENCES Inferior turbinate hypertrophy is one of the major causes of nasal airway obstruction causing significant impact on quality of life. Using the Nasal Obstruction Symptom Evaluation questionnaire Portuguese version (NOSE-p), the authors prospectively analyzed the outcomes in the quality of life of patients with inferior turbinate hypertrophy that underwent isolated RFTR in our department. The NOSE-p scores were obtained before surgery and at 1 month follow-up. In 87,5% of patients the NOSE–p score before surgery was greater than 70%. Our data demonstrated significant improvement from baseline after 1 month in 90,6% of patients. Therefore, we can conclude that RFTR remains a safe and efficient treatment for patients with nasal obstruction related to inferior turbinate hypertrophy. • Our sample was composed of 32 patients: • 23 females and 9 males. (chart 1) • The mean age was 36 years old. (chart 2) • 75% of patients referred symptoms of allergic rhinitis. (chart 3) • There were no complications related to the procedure. • The NOSE-p questionnaire was applied before surgery and 1 month after surgery. In 87,5% of patients the NOSE–p score before surgery was greater than 70%. (chart 4) • Our data demonstrated significant improvement from baseline after 1 month in 90,6% of patients. (chart 4) Using NOSE-p the authors prospectively analyzed the outcomes in the quality of life of patients with inferior turbinate hypertrophy that underwent isolated RFTR in our department in 2014 (fig.1). The NOSE-p scores were obtained before surgery and at 1 month follow-up. • CelonProBreath® bipolar electrode 1.1 mm diameter (fig.2&3) • Exclusion criteria: patients submitted to other surgical procedures The NOSE-p questionnaire showed a great improvement in the quality of life of patients that underwent RFTR. There weren’t complications related to the procedure. Therefore, we can conclude that RFTR remains a safe and efficient treatment for patients with nasal obstruction related to inferior turbinate hypertrophy. Inferior turbinate hypertrophy is one of the major causes of nasal airway obstruction causing significant impact on quality of life. Radiofrequency turbinate reduction (RFTR) is a minimally invasive surgical option that uses low-power radiofrequency energy within the submucosal tissue of the turbinate, reducing tissue volume with minimal impact on surrounding tissues. The Nasal Obstruction Symptom Evaluation (NOSE) instrument is a disease-specific questionnaire for assessing the outcome of an intervention in nasal obstruction. A validation of this questionnaire was made for Portuguese language by Bezerra et al. (NOSE-p). Mafalda Trindade Soares, MD Email: [email protected] OUTCOME OBJECTIVES Analyze the impact in quality of life and safety of Radiofrequency turbinate reduction (RFTR) in patients with inferior turbinate hypertrophy. Males 31% Females 69% 0 2 4 6 8 10 12 14 ≤ 25 years 26-45 years 46-65 years ≥ 65 years Nº patients n=32 n=32 Allergic Rhinitis 75% 25% n=32 Chart 1. Sex Chart 3. Allergic Rhinitis Chart 2. Age Chart 4. Quality of life (NOSE-p scores) before and after RFTR Figure 2 & 3. CelonProBreath® bipolar electrode 1.1 mm diameter Figure 1. Nasal Obstruction Symptom Evaluation portuguese version: Nose-p